Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs TD SYNNEX Corporation Common Stock (SNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs TD SYNNEX Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.87B), while TD SYNNEX Corporation Common Stock trades at $258.65 (market cap $22.02B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 2.5× Kymera Therapeutics Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and TD SYNNEX Corporation Common Stock for 0 Days on average.
| KYMR | SNX | |
|---|---|---|
Market Cap | $8.87B | $22.02B |
Volume | 779,107 | 614,208 |
Sector | Health | Technology |
52-Week High | $127.31 | $290.14 |
52-Week Low | $55.80 | $142.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $26.79B |
Dividend Yield | — | 0.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About TD SYNNEX Corporation Common Stock
TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →
